Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Rotarix (RIX4414) in Healthy Indian Infants
NCT00289172Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2006
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of human rotavirus vaccine, live attenuated in rotavirus infection, sponsored by GSK. Started Feb 2006; status: completed.
02
Drugs
human rotavirus vaccine, live attenuated
03
Conditions
rotavirus infection
Beyond the preview
Go deeper on NCT00289172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00289172.